Special Program of Assisted Reproduction

FUJIFILM Irvine Scientific Expands its Armstrong R&D Cell Culture Center of Excellence to Accelerate New Product Development and Broaden Service Offerings

Retrieved on: 
Wednesday, November 10, 2021
Health, Medical Devices, Other Construction & Property, Genetics, Construction & Property, Pharmaceutical, Biotechnology, ART, Product life-cycle theory, R, Technology, Virology, Special Program of Assisted Reproduction, Assisted reproductive technology, Growth, Cytogenetics, Cell biology, List of life sciences, Partnership, FUJIFILM, Medicine, Solution, Armstrong, MSAT, National Center for Manufacturing Sciences, Fine chemical

FUJIFILM Irvine Scientific, Inc., a world leader in providing cell culture solutions for Life Science and Medical markets, today announced the expansion of its Armstrong R&D Center of Excellence at its headquarters in California.

Key Points: 
  • FUJIFILM Irvine Scientific, Inc., a world leader in providing cell culture solutions for Life Science and Medical markets, today announced the expansion of its Armstrong R&D Center of Excellence at its headquarters in California.
  • This expansion marks an ongoing commitment to the advancement of discovery research, bioproduction, cell and gene therapy, assisted reproductive technologies and cytogenetics in its Life Sciences and Medical Media divisions.
  • Leveraging a deep understanding of cell biology and cell culture solutions, FUJIFILM Irvine Scientific continues to expand its diverse offering of specialty media, technologies, and custom media services.
  • said Bob Newman, chief scientific officer, FUJIFILM Irvine Scientific.

Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joins ClearPoint Neuro Board of Directors

Retrieved on: 
Tuesday, November 2, 2021
Linda, MRI, Special Program of Assisted Reproduction, BA, Brain, Quality of life, Neuro, UCLA Anderson School of Management, UCLA, Magnetic resonance, MBA, Brown University, CNS, Neurosurgery, Security (finance), U.S. Securities and Exchange Commission, Patient, FDA, Faculty, UCLA School of Nursing, Particular, Biopsy, Stanford University, Glioblastoma, Company, Research Excellence Framework, Board, CEO, NCI, COVID-19, Growth, Principal investigator, Lists of diseases, Solution, Nasdaq, David Geffen School of Medicine at UCLA, BS, Therapy, GLOBE, Doctor of Philosophy, Paper, Department, Medical imaging, Medical device

Dr. Linda M. Liau is Professor and W. Eugene Stern Chair of the Department of Neurosurgery at the David Geffen School of Medicine at UCLA.

Key Points: 
  • Dr. Linda M. Liau is Professor and W. Eugene Stern Chair of the Department of Neurosurgery at the David Geffen School of Medicine at UCLA.
  • After completing her residency and fellowship training in neurosurgery at UCLA, she joined the faculty at the UCLA School of Medicine.
  • Adding a practicing neurosurgeon and accomplished researcher to our board will be highly valuable to ClearPoint as we execute our mission to treat and transform the lives of patients suffering from the most debilitating neurological disorders.
  • The ClearPoint Neuro Navigation System has FDA clearance, is CE-marked, and is installed in over 60 active sites in the United States, Canada, and Europe.